These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 4882181

  • 1. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine.
    Muittari A, Mattila MJ, Tiitinen H.
    Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181
    [No Abstract] [Full Text] [Related]

  • 2. Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine.
    Muittari A, Mattila MJ, Patiala J.
    Ann Allergy; 1969 Jun; 27(6):274-9. PubMed ID: 4891707
    [No Abstract] [Full Text] [Related]

  • 3. Exercise-induced bronchospasm: evaluation of metaproterenol.
    Sly RM, Heimlich EM, Ginsburg J, Busser RJ, Strick L.
    Ann Allergy; 1968 May; 26(5):253-8. PubMed ID: 5654963
    [No Abstract] [Full Text] [Related]

  • 4. Sympathomimetic drugs in acute viral bronchiolitis. Their effect on pulmonary resistance.
    Phelan PD, Williams HE.
    Pediatrics; 1969 Oct; 44(4):493-7. PubMed ID: 5346627
    [No Abstract] [Full Text] [Related]

  • 5. [The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
    Cardaci G, Vittore F, Bussa B.
    Clin Ter; 1968 Jun 30; 44(6):533-41. PubMed ID: 5736873
    [No Abstract] [Full Text] [Related]

  • 6. [Experiences with a complex asthma therapy].
    Messerich J.
    Ther Ggw; 1967 Dec 30; 106(12):1601-2 passim. PubMed ID: 5622113
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of orciprenaline, ephedrine and methoxyphenamine as oral bronchodilators.
    Kerr A, Gebbie T.
    N Z Med J; 1973 May 30; 77(492):320-2. PubMed ID: 4578811
    [No Abstract] [Full Text] [Related]

  • 8. Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).
    Mattila MJ, Muittari A.
    Ann Med Exp Biol Fenn; 1969 May 30; 47(4):298-302. PubMed ID: 4911261
    [No Abstract] [Full Text] [Related]

  • 9. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of various dosage aerosols on asthmatic dyspnea (double-blind test)].
    Illig H.
    Med Klin; 1965 Sep 03; 60(36):1452-4. PubMed ID: 5324374
    [No Abstract] [Full Text] [Related]

  • 11. Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance.
    Bäcklund L, Fagerberg E.
    Scand J Respir Dis; 1968 Sep 03; 49(4):284-90. PubMed ID: 5194717
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma.
    Choo-Kang YF, Simpson WT, Grant IW.
    Br Med J; 1969 May 03; 2(5652):287-9. PubMed ID: 4888877
    [Abstract] [Full Text] [Related]

  • 14. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
    Racoveanu C, Stanescu DC, Manicatide M, Stroescu V.
    Postgrad Med J; 1971 Mar 03; 47():Suppl:83-6. PubMed ID: 4929399
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of Tranquo-Alupent in asthmatic syndrome].
    Gentschy E, Ott N.
    Ther Ggw; 1969 Sep 03; 108(9):1298 passim. PubMed ID: 4910102
    [No Abstract] [Full Text] [Related]

  • 16. TH1165a, a new bronchodilator: a clinical comparative evaluation with metaproterenol.
    Tweel HK.
    Ann Allergy; 1971 Mar 03; 29(3):142-7. PubMed ID: 5155518
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S, Tanaka Y, Wagatsuma Y, Miura R, Umezu A.
    Arerugi; 1971 Aug 03; 20(8):599-609. PubMed ID: 4398383
    [No Abstract] [Full Text] [Related]

  • 18. The effect of orciprenaline and its p-hydroxyphenyl derivative on the peak expiratory flow rate in asthmatic patients.
    Mattila MJ, Muittari A, Tiitinen H.
    Arzneimittelforschung; 1967 Mar 03; 17(3):362-4. PubMed ID: 4869818
    [No Abstract] [Full Text] [Related]

  • 19. [On the treatment of bronchial asthma].
    Scherrer M, Wyss F.
    Ther Umsch; 1967 Nov 03; 24(11):498-504. PubMed ID: 5600421
    [No Abstract] [Full Text] [Related]

  • 20. [Study of the bronchodilating action of Th 152].
    Hervê I, Pavani LM.
    Hospital (Rio J); 1966 Sep 03; 70(3):749-58. PubMed ID: 5300282
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.